Avidity Biosciences (RNA)
(Real Time Quote from BATS)
$46.12 USD
+1.00 (2.22%)
Updated Jul 22, 2024 02:52 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.76 |
EPS Last Quarter | -0.79 |
Last EPS Surprise | 2.47% |
ABR | 1.11 |
Earnings ESP
|
6.27% |
---|---|
Current Year | -3.15 |
Next Year | -3.28 |
EPS (TTM) | -2.95 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 7.09M | 7.09M | 17.14M | 24.99M |
# of Estimates | 1 | 1 | 3 | 2 |
High Estimate | 7.09M | 7.09M | 24.82M | 28.37M |
Low Estimate | 7.09M | 7.09M | 3.50M | 21.60M |
Year ago Sales | 2.32M | 2.82M | 9.56M | 17.14M |
Year over Year Growth Est. | 205.60% | 151.42% | 79.29% | 45.77% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.76 | -0.76 | -3.15 | -3.28 |
# of Estimates | 4 | 2 | 6 | 5 |
Most Recent Consensus | -0.93 | -0.95 | -3.26 | -2.83 |
High Estimate | -0.60 | -0.57 | -2.48 | -2.27 |
Low Estimate | -0.93 | -0.95 | -3.96 | -4.39 |
Year ago EPS | -0.66 | -0.71 | -2.91 | -3.15 |
Year over Year Growth Est. | -15.15% | -7.04% | -8.25% | -4.01% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.76 | -0.76 | -3.15 | -3.28 |
7 Days Ago | -0.76 | -0.76 | -3.15 | -3.28 |
30 Days Ago | -0.77 | -0.76 | -3.23 | -3.37 |
60 Days Ago | -0.76 | -0.76 | -3.10 | -3.28 |
90 Days Ago | -0.76 | -0.78 | -3.07 | -3.79 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.71 | -0.76 | -2.77 | -2.90 |
Zacks Consensus Estimate | -0.76 | -0.76 | -3.15 | -3.28 |
Earnings ESP | 6.27% | 0.00% | 12.11% | 11.53% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.79 | -0.79 | -0.71 | -0.66 | NA |
Estimate | -0.81 | -0.54 | -0.76 | -0.84 | NA |
Difference | 0.02 | -0.25 | 0.05 | 0.18 | 0.00 |
Surprise | 2.47% | -46.30% | 6.58% | 21.43% | -3.96% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more